SCHEMBL7974079

SCHEMBL7974079

O=c1[nH]c(-c2ccccc2)nc2ncn(Cc3ccccc3Cl)c12

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.45
ACP1 P24666 2/20 0.43
POLB P06746 2/20 0.41
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ROCK2 O75116 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PDE5A O76074 1/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985419 0.89 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2KMT2AHPGDACP1
SCHEMBL7975265 0.87 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7987219 0.86 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KMT2AHPGDPOLB
SCHEMBL7984786 0.86 SMN1; SMN2 (0.45) ALDH1A1SMN1; SMN2KMT2AHPGDPOLB
SCHEMBL7991402 0.85 SMN1; SMN2 (0.54) ALDH1A1SMN1; SMN2KMT2AHPGDMAPK1
SCHEMBL7984453 0.82 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KMT2AHPGDADORA3
SCHEMBL7974083 0.81 ACP1 (0.43) ALDH1A1SMN1; SMN2KMT2AACP1POLB
SCHEMBL7986518 0.81 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7984716 0.81 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2KMT2AHPGDPOLB
SCHEMBL7988662 0.81 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2KMT2AHPGDACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed